{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T19:16:50Z","timestamp":1769541410208,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-03953-8","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:38Z","timestamp":1769495978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysing ocular structural morbidities in younger adults using anti-seizure drugs: a cross-sectional study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8271-3490","authenticated-orcid":false,"given":"Rajalakshmi","family":"Selvam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"Miraclin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameena Parveen","family":"Nizam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"4","key":"3953_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/17512433.2019.1591274","volume":"12","author":"SA Hamed","year":"2019","unstructured":"Hamed SA (2019) Ocular dysfunctions and toxicities induced by antiepileptic medications: types, pathogenic mechanisms, and treatment strategies. Expert Rev Clin Pharmacol 12(4):309\u2013328. https:\/\/doi.org\/10.1080\/17512433.2019.1591274","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"3953_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ophtha.2003.04.004","volume":"113","author":"FT Fraunfelder","year":"2006","unstructured":"Fraunfelder FT, Sadun AA, Wood T, Yoon D (2006) Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology 113(1):134\u2013137. https:\/\/doi.org\/10.1016\/j.ophtha.2003.04.004","journal-title":"Ophthalmology"},{"issue":"4","key":"3953_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/0019-5545.171855","volume":"57","author":"SK Kar","year":"2015","unstructured":"Kar SK, Borasi Manish1, Kumar Deepak1, Gupta SK (2015) Carbamazepine induced optic neuropathy in an adolescent boy with conduct disorder: a rare case report. Indian J Psychiatry 57(4):437\u2013438. https:\/\/doi.org\/10.4103\/0019-5545.171855","journal-title":"Indian J Psychiatry"},{"issue":"10","key":"3953_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.4103\/ijo.IJO_978_16","volume":"65","author":"Y Totan","year":"2017","unstructured":"Totan Y, G\u00fcler E, Y\u00fcce A, Dervi\u015fogullar\u0131 MS (2017) The adverse effects of valproic acid on visual functions in the treatment of retinitis pigmentosa. Indian J Ophthalmol 65(10):984\u2013988. https:\/\/doi.org\/10.4103\/ijo.IJO_978_16","journal-title":"Indian J Ophthalmol"},{"issue":"10","key":"3953_CR5","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1007\/s00204-020-02835-x","volume":"94","author":"F Caiment","year":"2020","unstructured":"Caiment F, Wolters J, Smit E et al (2020) Valproic acid promotes mitochondrial dysfunction in primary human hepatocytes in vitro; impact of C\/EBP\u03b1-controlled gene expression. Arch Toxicol 94(10):3463\u20133473. https:\/\/doi.org\/10.1007\/s00204-020-02835-x","journal-title":"Arch Toxicol"},{"key":"3953_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.seizure.2022.01.011","volume":"96","author":"W Hu","year":"2022","unstructured":"Hu W, Chen L, Li H, Liu J (2022) Eye disorders associated with newer antiepileptic drugs: a real-world disproportionality analysis of FDA adverse event reporting system. Seizure 96:66\u201373. https:\/\/doi.org\/10.1016\/j.seizure.2022.01.011","journal-title":"Seizure"},{"issue":"3","key":"3953_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.18502\/jovr.v14i3.4795","volume":"14","author":"D Karuppannasamy","year":"2019","unstructured":"Karuppannasamy D, Andavar R, Arumugam J, Muthuvel K (2019) DRESS syndrome secondary to carbamazepine therapy presenting with bilateral acute anterior uveitis and angle closure glaucoma. J Ophthalmic Vis Res 14(3):382\u2013386. https:\/\/doi.org\/10.18502\/jovr.v14i3.4795","journal-title":"J Ophthalmic Vis Res"},{"issue":"6","key":"3953_CR8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.4103\/0028-3886.333440","volume":"69","author":"JP Rissardo","year":"2021","unstructured":"Rissardo JP, Fornari Caprara AL (2021) Lamotrigine-associated movement disorder: a literature review. Neurol India 69(6):1524\u20131538. https:\/\/doi.org\/10.4103\/0028-3886.333440","journal-title":"Neurol India"},{"issue":"3","key":"3953_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-256961","volume":"17","author":"M Chou","year":"2024","unstructured":"Chou M, Lai L, Neveu M, Ritchie A (2024) Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy. BMJ Case Rep 17(3):e256961. https:\/\/doi.org\/10.1136\/bcr-2023-256961","journal-title":"BMJ Case Rep"},{"issue":"5","key":"3953_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1034\/j.1600-0420.2000.078005580.x","volume":"78","author":"A Midelfart","year":"2000","unstructured":"Midelfart A, Midelfart E, Brodtkorb E (2000) Visual field defects in patients taking vigabatrin. Acta Ophthalmol Scand 78(5):580\u2013584. https:\/\/doi.org\/10.1034\/j.1600-0420.2000.078005580.x","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"3953_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022723","volume":"6","author":"S Rajakulendran","year":"2016","unstructured":"Rajakulendran S, Hanna MG (2016) The role of calcium channels in epilepsy. Cold Spring Harb Perspect Med 6(1):a022723. https:\/\/doi.org\/10.1101\/cshperspect.a022723","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3953_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/OPTH.S17754","volume":"5","author":"RN Hussain","year":"2011","unstructured":"Hussain RN, Banerjee S (2011) Presumed bilateral branch retinal vein occlusions secondary to antiepileptic agents. Clin Ophthalmol 5:609\u2013611. https:\/\/doi.org\/10.2147\/OPTH.S17754","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3953_CR13","first-page":"249","volume":"14","author":"T Seifert","year":"2016","unstructured":"Seifert T, Andersen G (2016) Mechanisms of optic nerve toxicity induced by antiepileptic drugs. Curr Neuropharmacol 14(3):249\u2013261","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"3953_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/11206721231207507","volume":"34","author":"P Gultutan","year":"2024","unstructured":"Gultutan P, Nalcacioglu P, Icoz M, Yilmaz D, Citak Kurt AN (2024) Ocular hemodynamics in epileptic children treated with antiepileptic drugs. Eur J Ophthalmol 34(3):843\u2013851. https:\/\/doi.org\/10.1177\/11206721231207507","journal-title":"Eur J Ophthalmol"},{"key":"3953_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainres.2012.03.025","volume":"1456","author":"MJ Thurtell","year":"2012","unstructured":"Thurtell MJ, Leigh RJ (2012) Effects of antiepileptic drugs on visual processing: evidence from functional MRI studies. Brain Res 1456:22\u201331. https:\/\/doi.org\/10.1016\/j.brainres.2012.03.025","journal-title":"Brain Res"},{"key":"3953_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2025.01.002","author":"K Bayat","year":"2025","unstructured":"Bayat K, Pooyan P, Looha MA, Namakin K, Carey AR, Arevalo JF, Ahmadieh H (2025) Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: a systematic review and meta-analysis of OCT findings. Surv Ophthalmol. https:\/\/doi.org\/10.1016\/j.survophthal.2025.01.002","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"3953_CR17","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9570.1000363","volume":"5","author":"D Barrett","year":"2014","unstructured":"Barrett D, Yang J, Sujirakul T, Tsang SH (2014) Vigabatrin retinal toxicity first detected with electroretinographic changes: a case report. J Clin Exp Ophthalmol 5(5):1000363. https:\/\/doi.org\/10.4172\/2155-9570.1000363","journal-title":"J Clin Exp Ophthalmol"},{"issue":"3","key":"3953_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/wnl.50.3.614","volume":"50","author":"GL Krauss","year":"1998","unstructured":"Krauss GL, Johnson MA, Miller NR (1998) Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 50(3):614\u2013618. https:\/\/doi.org\/10.1212\/wnl.50.3.614","journal-title":"Neurology"},{"issue":"4","key":"3953_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jnnp-2015-310521","volume":"87","author":"S Balestrini","year":"2016","unstructured":"Balestrini S, Clayton LM, Bartmann AP, Chinthapalli K, Novy J, Coppola A et al (2016) Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy. J Neurol Neurosurg Psychiatry 87(4):396\u2013401. https:\/\/doi.org\/10.1136\/jnnp-2015-310521","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3953_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043873","volume":"24","author":"K Ko\u015bmider","year":"2023","unstructured":"Ko\u015bmider K, Kamieniak M, Czuczwar SJ, Miziak B (2023) Second-generation antiepileptic drugs and oxidative stress. Int J Mol Sci 24(4):3873. https:\/\/doi.org\/10.3390\/ijms24043873","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3953_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4103\/0972-2327.144008","volume":"17","author":"B Menon","year":"2014","unstructured":"Menon B, Ramalingam K, Kumar RV (2014) Low plasma antioxidant status in patients with epilepsy and the role of antiepileptic drugs on oxidative stress. Ann Indian Acad Neurol 17(4):398\u2013404. https:\/\/doi.org\/10.4103\/0972-2327.144008","journal-title":"Ann Indian Acad Neurol"},{"issue":"9","key":"3953_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","volume":"11","author":"P Perucca","year":"2012","unstructured":"Perucca P, Gilliam FG (2012) Adverse effects of antiepileptic drugs. Lancet Neurol 11(9):792\u2013802. https:\/\/doi.org\/10.1016\/S1474-4422(12)70153-9","journal-title":"Lancet Neurol"},{"key":"3953_CR23","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/eye.2008.326","volume":"23","author":"V Belcastro","year":"2009","unstructured":"Belcastro V, Striano P, Ciampa C et al (2009) Is retinal assessment useful in epileptic patients with hyper-homocysteinemia? Eye 23:1532\u20131534. https:\/\/doi.org\/10.1038\/eye.2008.326","journal-title":"Eye"},{"key":"3953_CR24","unstructured":"Review of Optometry. Antiepileptic drugs and glaucoma. Available from: Vol. No:\u00a0139:11Issue:\u00a011\/15\/02 https:\/\/www.reviewofoptometry.com\/article\/antiepileptic-drug-and-glaucoma"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-03953-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-03953-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-03953-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:41Z","timestamp":1769495981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-03953-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3953"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-03953-8","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"74"}}